Novartis Ag (NVS, NVSEF)

CIK 1114448 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Novartis Ag.

Recent SEC filings

FiledFormAccession number
Oct 28, 20261440001959173-26-007516
Oct 27, 20266-K0001114448-26-000014
Oct 27, 2026SCHEDULE 13G/A0002012383-26-003726
Sep 8, 20266-K0001171843-26-005908
Sep 4, 20266-K0001171843-26-005896
Sep 1, 20266-K0001171843-26-005824
Jul 21, 20266-K0001114448-26-000012
Jun 11, 20266-K0001171843-26-004052
Apr 30, 20261440001959173-26-003145
Apr 28, 20266-K0001114448-26-000010
Mar 18, 20266-K0001104659-26-031037
Mar 17, 2026424B50001104659-26-029551
Mar 17, 2026FWP0001104659-26-028701
Mar 16, 2026424B50001104659-26-028048
Feb 12, 20261440001959173-26-000921
Feb 9, 20261440001959173-26-000748
Feb 4, 2026IRANNOTICE0001114448-26-000006
Feb 4, 202620-F0001114448-26-000004
Feb 4, 20266-K0001114448-26-000008
Feb 4, 20266-K0001114448-26-000007
Feb 4, 2026S-80001104659-26-010334
Jan 16, 2026S-8 POS0001104659-26-004590
Jan 16, 2026S-8 POS0001104659-26-004593
Jan 16, 2026S-8 POS0001104659-26-004592
Jan 16, 2026S-8 POS0001104659-26-004591